RxDoctor Payments Data
★ My doctorsLook up a doctor →

Daniel Hoft

Infectious Disease · St Louis, MONPI 1730197617

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,600 of the $19,686 with a category attached, or 99.6%. 3 manufacturers reported payments, led by GSK at 56.1% of the total. Among infectious disease clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,686in general payments, 2019–2025

Across 6 payments — averaging $3280.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$11K
  • Modernatx, Inc.$9K
  • Sanofi Pasteur Inc.$86
$553,677in research payments, 2019–2025

Across 31 payments — averaging $17,861 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biomerieux Inc$554K

What the payments were for

  • Consulting fees$19,600100%
  • Food & beverage$860%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK1$11,050
Modernatx, Inc.3$8,550
Sanofi Pasteur Inc.2$86

How this compares

$19,686 in reported general payments places this provider in the 95th percentile of 177 infectious disease providers in Missouri.

See all infectious disease providers in Missouri →

Other infectious disease in St Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →